Coxsackie B virus infection in idiopathic dilated cardiomyopathy clinical and pharmacological implications

BioDrugs

Volumn 15, Issue 12, 2001, Pages 791-799

  Fujioka, Shigekazu ^a   Kitaura, Yasushi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 [5 [2,6 DICHLORO 4 (4,5 DIHYDRO 2 OXAZOLYL)PHENOXY]PENTYL] 3 METHYLISOXAZOLE; ALPHA INTERFERON; ANTIVIRUS AGENT; PLECONARIL; RIBAVIRIN;

ANTIVIRAL ACTIVITY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; COXSACKIE VIRUS INFECTION; HUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CARDIOMYOPATHY, DILATED; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; HEART; HUMANS; TREATMENT OUTCOME;

EID: 34447616807     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200115120-00002     Document Type: Article

References (1)

1. Rueckert RR. Picomaviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howly PM, editors. Fields virology. Philadelphia: Wolters Kluwer, 1995: 626-8